HCP Q3 Beats on Earnings and Revs - Analyst Blog
October 29 2013 - 1:37PM
Zacks
Aided by growth in revenues, HCP Inc. (HCP) – a
healthcare real estate investment trust (REIT) – reported third
quarter 2013 adjusted FFO (funds from operations) per share of 79
cents, 2 cents ahead of the Zacks Consensus Estimate and 10 cents
above the prior-year quarter figure.
HCP reported total revenue of nearly $544.0 million during the
quarter, reflecting an increase of 16.2% from the year-ago period.
Total revenue also exceeded the Zacks Consensus Estimate of $514
million.
Adjusted same-property net operating income (NOI) of the company
reached $359.8 million in the quarter depicting growth of 3.7% year
over year.
Notably, the company received £129 million ($202 million) from the
par payoff of its Barchester debt investments. This led to an
income of 5 cents per share. Including severance-related charges
for the termination of the company’s former Chairman, Chief
Executive Officer and President on Oct 2, 2013 as well as
impairments in the prior-year quarter, FFO came in at 73 cents per
share, up from 67 cents reported in the prior-year period.
Notable Activities
During the quarter, HCP funded $55 million for construction and
other capital projects, mainly in its life science, medical office
and senior housing divisions. Moreover, in July, the company
extended its ties with life science tenant, Roche/Genentech, in
South San Francisco, CA. In particular, HCP executed a new
five-year lease for a 63,000 sq. ft. building, leading to a total
of 857,000 sq. ft. in leasing.
In September, HCP bought a 60-bed inpatient rehabilitation facility
from Kindred Healthcare in Webster, Texas that was valued at $15
million. As part of the exchange, the company sold a 62-bed
hospital in Greenfield, WI. The move resulted in a gain of $8
million and helped improve the master lease coverage.
Following the quarter end, HCP established its ties with a genomic
diagnostics tenant, CardioDx, at its Redwood City, California life
science campus, through the execution of an eight-year, 69,000 sq.
ft. new lease deal. Notably, the lease with CardioDx will anchor
around 75% of two redevelopment buildings that were repositioned in
2011.
The company also disclosed the resignation of James F. Flaherty
from its board of directors on Oct 28.
Liquidity
At the end of the quarter, HCP had cash and cash equivalents of
$49.4 million, down from $53.1 million at the prior-quarter
end.
Outlook
HCP expects adjusted FFO to range between $2.97 and $3.03 per share
for full-year 2013. The mid-point of the estimate reflects a rise
of 8% over the 2012 comparable figure. The estimates exclude the
impact of any future acquisitions or dispositions.
Dividend Update
On Oct 24, 2013, HCP announced a quarterly common stock cash
dividend of 52.5 cents per share. The dividend will be paid on Nov
19, 2013 to stockholders of record as of the close of business on
Nov 4.
In Conclusion
We believe that going forward, HCP is well poised for a strong
growth trajectory given its well-balanced, diversified portfolio,
opportunistic acquisitions, aging population, rising healthcare
expenses, decent balance sheet, and improving credit metrics.
However, the company’s dependence on a limited number of operators
and tenants for a large share of its revenues is a concern. Also,
cut-throat competition remains a deterrent.
HCP currently carries a Zacks Rank #3 (Hold).
Another healthcare REIT, Ventas Inc. (VTR),
reported third-quarter 2013 normalized funds from operations (FFO)
per share of $1.04, which exceeded the Zacks Consensus Estimate of
$1.02 by nearly 2% and the year-ago quarter figure by 8.3%.
Results were driven by strategic investments made this year and
last year. In particular, the company experienced an uptick in net
operating income in its private pay seniors housing communities,
triple-net lease portfolio and medical office building segment.
We now look forward to the results of Healthcare Realty
Trust Inc. (HR) (scheduled to report on Oct 30) and
Health Care REIT Inc. (HCN) (Nov 5).
Note: FFO, a widely used metric to gauge the performance of
REITs, is obtained after adding depreciation and amortization and
other non-cash expenses to net income.
HEALTH CR REIT (HCN): Free Stock Analysis Report
HCP INC (HCP): Free Stock Analysis Report
HEALTHCARE RLTY (HR): Free Stock Analysis Report
VENTAS INC (VTR): Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
Welltower OP (NYSE:WELL)
Historical Stock Chart
From Jan 2025 to Feb 2025
Welltower OP (NYSE:WELL)
Historical Stock Chart
From Feb 2024 to Feb 2025